Replies to post #146046 on NanoViricides Inc. (NNVC)

[loanranger]

I think this sums it up...
" All we need to know is that Diwan takes care of Diwan first."
....but there's a lot going on here.

Covid is losing its grip on India if the WHO's numbers are to be believed and there's a geographical limit on that very generous sounding 70% royalty:
"Karveer is not required to pay any minimum royalties, nor any license maintenance fees. Should Karveer manufacture the drugs for sales by NanoViricides outside the Territory, there will be no royalty payable on such sale of the drug products, and NanoViricides shall pay Karveer for such drug product purchases from Karveer at a rate that will be negotiated from time to time between the Parties."

But the only real issue is whether the science is as compelling as you once found it to be. Is it still? Because only if it is should NNVC investors start counting their chickens or worrying about things like who gets what. If it isn't then Diwan has only created a new way to get money from NNVC to Diwan.